[Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis].
In patients with metastatic prostate cancer presenting with synchronous bone metastases, the surgical removal of the primary is an experimental treatment approach. In the following article, we evaluate the rationale for this approach.
Urologische Klinik des Klinikums der Universität München, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
A
A
Spek
Urologische Klinik des Klinikums der Universität München, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
A
A
Herlemann
Urologische Klinik des Klinikums der Universität München, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland.
C
C
Gratzke
Urologische Klinik des Klinikums der Universität München, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland. christian.stief@med.uni-muenchen.de.
C G
CG
Stief
D001859:Bone Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy*; D000066491:Clinical Decision-Making / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000517:prevention & control; D015995:Prevalence; D011379:Prognosis; D011468:Prostatectomy / Q000401:mortality* / Q000706:statistics & numerical data*; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome
Hormone chemotherapy; Lymphatic metastasis; Metastasis; Multimodal approach; Therapy, cytoreductive